Overview
France eyewear group's Q1 revenue rose 10.8% at constant exchange rates
Double-digit growth in Professional Solutions and Direct to Consumer segments
Company expanded retail footprint in Thailand with Top Charoen deal
Outlook
Company did not provide specific financial guidance for the current or future periods
Result Drivers
AI GLASSES AND RAY-BAN - Co said strong sales of AI glasses and Ray-Ban brand supported growth in North America and EMEA
MYOPIA MANAGEMENT - Myopia management portfolio grew 26%, with China up 18% and retail expansion contributing
RETAIL EXPANSION - Top Charoen deal added around 2k stores in Thailand, expanding the Group’s network to nearly 20k locations
Company press release: ID:nGNE4WXqj1
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 7.13 bln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 23 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Essilorluxottica SA is €320.00, about 54.8% above its April 21 closing price of €206.70
The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 34 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)